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Summary 
The avian ciliary ganglion contains choroid neurons 
that innervate choroid vasculature and express so- 
matostatin as well as ciliary neurons that innervate iris/ 
ciliary body but do not express somatostatin. We have 
previously shown in culture that acUvin A induces so- 
matostatin immunoreactivity in both neuron popula- 
tions. We now show in vivo that both targets contain 
activin A; however, choroid expressed higher levels 
of activin A mRNA. In contrast, follistatin, an activin 
A inhibitor, was higher in iris/ciliary body. Iris cell- 
conditioned medium also contained an activity that 
inhibited activin A and could be depleted with anti- 
follistatin antibodies. These results suggest that 
development of somatostatin is limited to choroid 
neurons by differential expression of activin A and fol- 
listatin in ciliary ganglion targets. 
Introduction 
The influence of target tissues on the neurotransmitter 
phenotype of developing neurons has been well estab- 
lished (reviewed in Landis, 1990; Dryer, 1994; Nishi, 
1994). For example, in the developing sympathetic ner- 
vous system, noradrenergic sympathetic neurons switch 
to a cholinergic phenotype upon contact with the sweat 
gland target cells in the rat footpad (Leblanc and Landis, 
1986; Landis, 1994). This transition is regulated by a diffus- 
ible target-derived factor (Schotzinger and Landis, 1988; 
Stevens and Landis, 1990; Habecker et al., 1995). Neural 
plasticity of a similar type regulated by exogenous mole- 
cules has been demonstrated in vitro. Sympathetic neu- 
rons have been shown to undergo an adrenergic to cholin- 
ergic switch when cocultured with cardiac myocyte- 
conditioned medium (Furshpan et al., 1976; Weber, 1981 ; 
Potter et al., 1986). This effect has been shown to be due to 
the presence of leukemia inhibitory factor (Fukada, 1985; 
Yamamori et al., 1989) in the conditioned medium. Addi- 
tion of ciliary neurotrophic factor (CNTF) to cultures of 
sympathetic neurons also induces an adrenergic to cholin- 
ergic switch (Saadat et al., 1989; Ernsberger et al., 1989). 
However, transgenic mice deficient for leukemia inhibitory 
factor were found to have normal sweat gland innervation 
and function (Rao et al., 1993). In addition, vasoactive 
intestinal peptide immunoreactivity and choline acetyl- 
transferase (CHAT) activity in the footpad sweat glands 
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of transgenic mice deficient for CNTF were unchanged 
compared with wild type (Masu et al., 1993). These results 
suggest that these factors are not essential to the regu- 
lation of neurotransmitter phenotype in vivo. Although 
evidence demonstrates that target-derived factors are 
important o the development of neurotransmitter pheno- 
type, there is limited understanding of the specific mole- 
cules that regulate the processes in the developing em- 
bryo (reviewed in Patterson and Nawa, 1993). 
We have used the avian ciliary ganglion to investigate 
the effect of target-derived molecules on the regulation of 
neurotransmitter phenotype. In the ciliary ganglion, two 
distinct neuronal populations innervate separate targets 
in the eye (Marwitt et al., 1971). The ciliary neurons inner- 
vate the striated muscle of the iris and ciliary body to regu- 
late pupilary dilation and lens accommodation. The cho- 
roid neurons innervate the smooth muscle surrounding 
the arterial vascuiature of the choroid layer and aid in oxy- 
genation of the eye. These neuronal populations have the 
same neural crest derivation (Narayanan and Narayanan, 
1978), receive preganglionic input from the accessory ocu- 
Iomotor nucleus (Narayanan and Narayanan, 1976), and 
synthesize acetylcholine as the primary neurotransmitter 
(Burt and Narayanan, 1976; Chiappinelli et al., 1976; Cou- 
Iombe and Bronner-Fraser, 1990). However, only the cho- 
roid neurons express the neuromodulatory peptide so- 
matostatin (Epstein et al., 1988; De Stefano et al., 1993), 
which has been shown to regulate acetylcholine release 
(Guillemin, 1976; Gray et al., 1990). 
Neurons isolated from the ciliary ganglion and main- 
tained in culture have been used to characterize the mole- 
cules that regulate somatostatin expression. Previous 
studies showed that choroid muscle cells will induce so- 
matostatin expression in ciliary ganglion neurons in vitro. 
The ability of ciliary neurons to express somatostatin in 
culture was shown by retrograde labeling of the neuron 
cell bodies before placing them in culture (Coulombe and 
Nishi, 1991). The choroid cell-derived, somatostatin- 
stimulating activity was shown to be due to activin A (Cou- 
Iombe et al., 1993). 
Activin A has been implicated as a regulator in many 
different physiological and developmental processes (for 
review, see Ying, 1989). Activin A is a homodimer of the 
inhibin I~A chain (Mason et al., 1985) and was originally 
described as having a stimulatory effect on the release of 
follicle-stimulating hormone from the pituitary gland. The 
action of activin A in vivo is negatively regulated by fol- 
listatin (Ling et al., 1985; Nakamura et al., 1990), an activin 
A-binding protein (Kogawa et al., 1991; Sumitomo et al., 
1995). During early embryonic development in Xenopus, 
the action of the more widely distributed activin A is regu- 
lated by localized expression of follistatin (Hemmati- 
Brivanlou and Melton, 1992, 1994a, 1994b). Exogenous 
activin A has been shown in vitro to promote survival of 
some neurons (Schubert et al., 1990) and to increase 
mRNA levels for several neuropeptides in sympathetic 
neurons (Fann and Patterson, 1994). 
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Figure 1. Chick Follistatin Fragment Sequence and Amino Acid Com- 
parison with other Species 
(A) The 223 bp fragment of chick follistatin was cloned by RT-PCFI 
and sequenced. Primer regions were underlined. 
(B) A comparison of the amino acid translation of the chick fragment 
(C) against human (H), pig (P), Xenopus (X), and mouse (M) follistatin 
showed relative conservation at the amino acid level. The accession 
number for chick follistatin is U34589. 
We have examined whether the differential expression 
of activin A and follistatin in targets innervated by ciliary 
ganglion neurons results in the differential induction of 
somatostatin expression. Our results suggest that suffi- 
cient activin A is available at the choroid layer to induce 
somatostatin in choroid neurons, but the presence of ex- 
cess follistatin in the iris prohibits an induction of somato- 
statin in the ciliary neurons. 
Results 
Chicken-Specific Probes for Follistatin and 
Activin A 
To investigate the expression of activin A and follistatin 
mRNA, chicken-specific probes were obtained. Cloning 
of follistatin from several species has shown that there is 
one gene product (Shimasaki et al., 1988a, 1988b; Albano 
et al., 1994) that encodes several protein isoforms arising 
from alternatively spliced mRNA and posttranslational 
modifications (reviewed in Sugino et al., 1993). A cDNA 
fragment of follistatin was amplified from embryonic chick 
ovary RNA using reverse transcriptase-polymerase chain 
reaction (RT-PCR). The primers were designed based on 
a conserved region of cloned foltistatin sequences from 
other species (Hemmati-Brivanlou and Melton, 1994b; 
Shimasaki et al., 1988a, 1988b). The PCR product was 
ligated into the pCRII vector and sequenced (Figure 1A). 
Riboprobes generated from this construct were de- 
signed to recognize all mRNA splice variants described. 
Comparison of the deduced amino acid sequence en- 
coded by this fragment with follistatin proteins from other 
species revealed a high degree of conservation (Figure 
1B). A full-length cDNA clone of chick activin A (inhibin 
13A) was obtained from Dr. Patricia Johnson (Chen and 
Johnson, 1994, Biol. Reproduct., abstract). The region 
used for activin A probe synthesis was not homologous 
to the inhibin (z transcript or the inhibin ~B transcript. 
MulUprobe RNase Protection Assay 
To compare both activin A and follistatin mRNA transcript 
levels in the same sample, a multiprobe RNase protection 
assay was used (Qian et al., 1993). To determine the sensi- 
tivity of this assay, the linear range of detection was deter- 
mined for each of the probes. Activin A and follistatin 
mRNA levels were measured in the same sample, mRNA 
levels of a constitutively expressed gene, chick ribosomal 
binding protein $17 (CHRPS; Tr~ieb et al., 1988), were 
measured as an internal loading control. Total RNA from 
embryonic day 17 (E17) chick ovary was used to establish 
muitiprobe assay conditions, as both of these proteins are 
known to be present within this tissue (Mason et al., 1985; 
Vale et al., 1986). Probe sizes were chosen to prevent 
overlap in the protected fragments. To demonstrate the 
sensitivity of this assay, protected bands for activin A, fol- 
listatin, and CHRPS were detected in RNA from embryonic 
ovary (Figure 2, left). Unprotected probe (Figure 2, right) 
showed the predicted size prior to processing. No pro- 
tected fragments were detected when yeast tRNA was 
used in place of tissue RNA. Chick genomic DNA was also 
negative (data not shown). Relative intensity measure- 
ments of the signal from the protected fragments were 
obtained from a scanned phosphorimage. The signal in- 
creased with increasing amounts of total RNA, and the 
signals were linear for all three probes tested (Figure 2B). 
In subsequent experiments, we chose conditions from tis- 
sues that would yield signals within the linear range of 
sensitivity of this assay. 
Activin A and Follistatin mRNA in the Developing 
Iris and Choroid 
If activin A and follistatin regulate the expression of so- 
matostatin in ciliary ganglion neurons in vivo, mRNA for 
these factors should be detectable in the targets of the 
ciliary ganglion during development. E9-E16 encompass 
a critical period of development during which both the iris/ 
ciliary body (Pilar et al., 1980, 1987) and choroid (Meriney 
and Pilar, 1987) tissues mature as they become inner- 
vated. In particular, somatostatin expression increases 
during this period until all the choroid neurons express 
the neuropeptide at E14 (Smet and Rush, 1993). RNase 
protection analyses of RNA from E9-E16 iris and E9-E16 
choroid were done in parallel to compare RNA levels for 
activin A and follistatin (Figu re 3A). Analysis of ciliary body 
mRNA was not performed because isolation of uncontami- 
nated ciliary body separate from neural retina and lens 
epithelium is difficult to obtain. Follistatin and activin A 
transcripts in the iris increased from E9 to E16 (Figure 
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Figure 2. Multiprobe RNase Protection Assay Standard Curve 
(A) An autoradiograph of 5-40 ~g of E17 chick ovary total RNA hybrid- 
ized with activin A, follistatin, and CHRPS probes. All three protected 
fragments (arrows) were visible in each sample. Unprotected probe 
(A, F, and C) ran higher than the protected fragments. The tRNA nega- 
tive control (t; 20 FLg of RNA) had no protected fragments. 
(B) A logarithmic plot of the scanned phosphorimage showed a linear 
increase in signal intensity relative to increases in RNA concentration 
(r = 0.999 for activin A; r = 0.992 for follistatin; r = 0.994 for CHRPS). 
This is a representative xperiment from four repetitions that show 
similar results. Circles, CHRPS; squares, activin A; diamonds, fol- 
listatin. 
3B). In contrast,  fol l istatin mRNA levels in choro id re- 
ma ined low relat ive to the iris through all ages  tested. 
Activin A mRNA was high f rom E9 to E14 but d ropped at 
E16 (F igure 3C). These results indicate a str ik ing differ- 
ence  in mRNA express ion  for activin A and fol l istatin be- 
tween the two target t issues of  the cil iary gangl ion  neu- 
rons. The  observat ions  that fol l istatin mRNA levels in the 
choroid were  lower than those in the iris, whi le the level 
of  activin A was  higher in the choroid than in the iris, sup- 
port  the hypothes is  that di f ferent ia l  express ion  of these 
factors in the two targets leads to a di f ferent ia l  express ion  
of  somatostat in  in the neurons  that innervate them. 
Immunolocalization of Activin A and Follistatin to 
Target Tissues of Ciliary Ganglion Neurons 
To demonst ra te  that express ion  of activin A and fol l istatin 
protein corre lates  with their  respect ive mRNA express ion  
B 
C 
09 
t~ 
< 
Z 
O 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0 
Ir is 
0.6 
~ 0.5 
~ 0.4 
"t3 0.3 
N 
0.2 
t~ 
0.1 
0 
0 
jpt I11 
..m~ / 
I I I l 
10 12 14 16 
Choro id  
18 
• . . . . .  -m . . . . . . . . .  | 
it 
C>------x> O-~ 
~'--o 
8 ;0 ;2 14 1L 18 
embryonic day 
Figure 3. Follistatin and Activin A in Iris and Choroid Tissue during 
Development 
(A) An autoradiograph of 20 ~g each of E9-E16 iris and E9-E16 cho- 
roid total RNA after protection with activin A, follistatin, and CHRPS 
probes showed all three protected fragments (arrows) were visible in 
each sample. Unprotected probe (A, F, and C) ran slightly higher than 
the protected fragments. Adult ovary was run as a positive control (o; 
20 p.g of total RNA). The tRNA negative control (t; 20 p.g) had no 
protected fragments. 
(B and C) Normalized RNA values for activin A and follistatin were 
determined as a ratio of relative signal intensity for each probe over 
the relative intensity for CHRPS, within the same sample. Follistatin 
and activin A mRNA in the iris increased from E9 to E16 (B). Follistatin 
in the choroid remained static, while activin A was high from E9 to 
E14 and dropped at E16 (C). This is a representative xperiment from 
four repetitions showing simitar results. Squares, activin A; circles, 
follistatin. 
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Figure 4. Activin A and Follistatin Immunolocatization in Ciliary Ganglion Neuron Targets In Vivo 
Cryostat sections of Ell ciliary body (A-C) and iris (D-F) show double peroxidase anti-peroxidase staining for activin A (A and D, arrows) and 
follistatin (B and E, arrows). Sections of E12 choroid reveal strong staining for activin (G, arrows) but not for follistatin (H). Normal rabbit serum 
staining was included as a control. Arrows indicate comparable target areas (C, F, and I). Pigment epithelium staining could not be assessed 
owing to high pigment granule content in these cells. C, cornea; CB, ciliary body; Ch, choroid layer; I, iris stroma; PE, pigmented epithelium; S, 
sclera. Bar, 700 ~m (A-F), 450 p.m (G-I). 
patterns, antisera produced against activin A (Vaughan 
et al,, 1989; Kokan-Moore et al., 1991) and follistatin (Su- 
gawara et al., 1990; Petraglia et al., 1994) were used to 
immunolocalize these proteins to targets of ciliary gan- 
glion neurons. Activin A immunoreactivity was first de- 
tected at E l l  in the developing ciliary body (Figure 4A) 
and iris (Figure 4D). In the choroid layer, activin A immune- 
reactivity could be seen at E12 (Figure 4G), the earliest age 
at which reliable histology could be obtained. Follistatin 
immunoreactivity was also observed at E11 in the muscu- 
lature of the ciliary body (Figure 4B) and the iris stroma 
(Figure 4E); however, at E12 in the choroid layer, follistatin 
immunoreactivity was not detectable (Figu re 4H). Specific- 
ity of the activin A and follistatin immunostaining was as- 
sessed with normal rabbit serum (Figures 4C, 4F, and 41). 
In addition, preabsorption of anti-activin A with the peptide 
used to generate the antiserum displayed no immunoreac- 
tivity above background on adjacent sections (data not 
shown). 
Iris Cell-Conditioned Medium Inhibits Somatostatin 
Induction in Ciliary Ganglion Neurons 
The biological role of activin A and follistatin expression 
in the choroid and iris was investigated using cells derived 
from these target tissues in a bioassay that measured their 
effects on somatostatin induction in ciliary ganglion neu- 
rons. To confirm that cultured choroid and iris cells ex- 
pressed activin A and follistatin, levels of mRNA were mea- 
sured using RNase protection. Follistatin mRNA levels 
were similar in both iris and choroid cells in culture (Figure 
5). Activin A was approximately 4-fold higher in the choroid 
cells relative to the iris cells. These relative mRNA levels 
for activin A and follistatin were similar to the ratios seen 
at E l l  in the targets in vivo (see Figure 4). Synthesis of 
activin A and follistatin protein was assessed using immu- 
nocytochemistry (Figure 6). Activin A immunoreactivity 
was found as punctate perinuclear staining m multiple cell 
types of iris cultures (Figure 6A). Similar punctate staining 
was found in choroid smooth muscle cells (Figure 6D). 
Follistatin immunoreactivity was most dramatic in iris cul- 
ture myotubes (Figure 6B) but was weak in choroid smooth 
muscle cells (Figure 6E). As a control, choroid and iris 
cultures were stained after replacing the primary antise- 
rum with normal rabbit serum (Figures 6C and 6F). 
To determine the ability of iris cell-conditioned medium 
(ICM) to inhibit the induction of somatostatin, we used the 
same bioassay that was previously used to identify activin 
A as an inducer of somatostatin expression in ciliary gan- 
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Cultures 
Total RNA (10 pg) from cells in culture was hybridized to activin A, 
follistatin, and CH RPS probes. The histogram of the normalized RNA 
values from this protection are shown for activin A (closed bars) and 
follistatin (open bars). RNA values were obtained using the ratio of 
the relative intensity of probe signal to the relative intensity of the 
loading control, CHRPS. The follistatin RNA value was similar in the 
iris and choroid cells in culture. In contrast, the activin A value was 
approximately 4-fold higher in the choroid cells than in the iris cells. 
One representative experiment ou of four repetitions with similar re- 
sults is shown. 
glion neurons (Coulombe et al., 1993). Serum-free condi- 
t ioned medium from iris-derived cultures (ICM) that con- 
tained myotubes was concentrated and added to E8 ciliary 
ganglion neurons cultured in the presence or absence of 
10 ng/ml recombinant activin A. This dose of activin A was 
previously demonstrated to be within the linear range for 
somatostatin induction (Coulombe et al., 1993). ICM signif- 
icantly reduced (p < .05) the percentage of neurons that 
express somatostatin immunoreactivity when compared 
with neurons grown in control medium (Figure 7A). To 
investigate whether this inhibition of somatostatin immu- 
noreactivity was mediated by the secretion of follistatin by 
iris cells, ICM was immunodepteted with an anti-follistatin 
antiserum (Sugawara et al., 1990). Immunodeplet ion sig- 
nificantly restored somatostatin induction in the presence 
of activin A (p < .05 as compared with ICM treatment). 
Immunodepleted ICM in the absence of activin A did not 
stimulate somatostatin induction, suggesting that activin 
A may be bound to follistatin and removed with follistatin 
immunodepletion. Quantitation of activin A and follistatin 
protein levels in ICM was not analyzed. To control for dele- 
terious effects of ICM on ciliary ganglion neurons, neu- 
ronal survival and ChAT activity were assayed. Neither 
survival nor ChAT activity was reduced in the presence 
of ICM (Figures 7B and 7C). The bioassay results, together 
with the different expression patterns of activin A and fol- 
listatin, support our hypothesis that activin A signaling in 
the iris is selectively inhibited by follistatin protein and reg- 
ulates somatostatin phenotype in ciliary ganglion neurons. 
Discussion 
In the current study, we have investigated the in vivo distri- 
bution of activin A and follistatin and the in vitro potential 
of ICM to modulate somatostatin induction. Previous work 
from our laboratory has shown that activin A from choroid 
cel l -condit ioned medium induces somatostatin expres- 
sion in ciliary ganglion neurons (Coulombe et al., 1993). 
Using an RNase protection assay, we have now demon- 
strated that activin A mRNA is present in both target tis- 
sues of the ciliary ganglion neurons but is higher in the 
choroid than in the iris. In contrast, follistatin mRNA is 
higher in the iris. In agreement with these results, immuno- 
staining for activin A and follistatin indicates that activin 
Figure 6. Activin A and Follistatin Immunoreactivity in 6-Day-Old Choroid and Iris Cultures 
Iris cultures (A-C) show punctate, perinuclear staining for activin A in multiple cell types, including multinucleated myotubes (A, arrows). Choroid 
(D-F) cultures reveal similar punctate staining patterns (D, arrows). Follistatin immunoreactivy (B and E) is most dramatic in iris-derived myotubes 
(B, arrows). Normal rabbit serum staining wasincluded as a control (C and F). Nuclei in myotubes showed nonspecific staining as assessed with 
the normal rabbit serum (C, arrows), while choroid cells were negative (F, arrows). Bar, 75 p.m. 
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Figure 7. Somatostatin Induction, Neuron Survival, and ChATActivity 
in Cultured Ciliary Ganglion Neurons 
Percentage of somatostatin mmunoreactivity (A), neuron survival (B), 
and ChAT activity (C) were measured in ciliary ganglion eurons cul- 
tured for 4 days in control medium (Ctrl), iris cell-conditioned medium 
(ICM), or ICM that had been immunodepleted with an antibody specific 
for follistatin (ICM/eFS). Ciliary ganglion euron cultures from each 
experimental condition were maintained with 10 ng/ml activin A (closed 
bars) or without activin A (gray bars). The values indicated for each 
column are the mean of three different cultures from one representa- 
tive experiment. Error bars represent SD. Single asterisk, significantly 
differs from control with activin A; double asterisk, significantly differs 
from ICM with activin A; triple asterisk, ICM&FS with and without 
activin ChAT activity significantly differs from control with or without 
activin A. Significance at p < .05 by one-way ANOVA. 
A is present in both choroid and iris, while follistatin is 
detectable only in the iris during the period of somatostatin 
induction. Moreover, the immunohistochemical results 
have localized both proteins to the iris/ciliary body and the 
choroid layer, regions that contain the target cells for ciliary 
and choroid neurons. As previously noted, iris- and cho- 
roid-derived cells in culture produce factors that can influ- 
ence transmitter phenotype. Choroid cell-conditioned me- 
dium induces somatostatJn and contains activin A, which 
alone can induce somatostatin (Coulombe et al., 1993). 
We have now shown that ICM inhibits somatostatin induc- 
tion and that this inhibition is significantly relieved by im- 
munodepletion of ICM with anti-follistatin antibodies. A 
model that accounts for these findings is that activin A 
produced in the choroid layer induces somatostatin in the 
choroid neurons, but activin A signaling in the iris and 
ciliary body is blocked by local production of follistatin. 
Several additional observations led to other areas of 
inquiry. The increasing expression of activin A and fol- 
listatin in the iris correlates with increasing neuronal in- 
nervatJon in this target tissue. Although these studies do 
not address whether innervation may regulate activin A 
and follistatin expression, such regulation of target- 
derived factors has been demonstrated in sympathetic in- 
nervation of rodent sweat glands. Production of sweat 
gland factor activity, which induces the noradrenergic to 
cholinergic switch, is dependent on proper innervation 
(Habecker and Landis, 1994; Habecker et al., 1995). While 
cultures of choroid and iris cells produce activin A and 
follistatin independently of innervation in vitro (see Figures 
5 and 6), the sources of these cultures are innervated at 
the time of removal. In addition, there is a decrease in 
activin A mRNA levels seen consistently at E16 in the 
choroid (see Figure 3). The dependence of ciliary ganglion 
neurons on activin A for maintenance of somatostatin ex- 
pression has been shown up to E14 in vitro (Coulombe 
and Nishi, 1991). Potentially, this decrease at E16 reflects 
a loss of dependence on activin A once the adult neuro- 
transmitter phenotype has been established. Finally, 
ChAT activity consistently increased in ciliary ganglion cul- 
tures treated with ICM or ICM that had been depleted with 
anti-follistatin antibodies (Figure 7C), indicating that fol- 
listatin is not regulating ChAT activity. Although a target- 
derived ChAT induction in ciliary ganglion neurons has 
been demonstrated previously (Nishi and Berg, 1979; Tut- 
tie et al., 1983), factors that affect ChAT activity remain 
to be purified. 
The identification of follistatin transcripts and immunore- 
activity in the developing iris is complemented by the ap- 
propriate biological activity in ICM observed in the somato- 
statin induction assay. The significant but partial relief of 
inhibition of somatostatin induction by follistatin-immuno- 
depleted ICM (see Figure 7A) demonstrates the presence 
of follistatin. The lack of complete relief of inhibition could 
be explained by several alternatives. One plausible expla- 
nation is that the antibodies used for the immunodepletion 
were generated against porcine follistatin and thus may 
not be able to recognize all the possible isoforms of 
chicken follistatin. Another possibility is that other inhibi- 
tors of somatostatin induction may be present in the ICM. 
Interestingly, we do not see induction of somatostatin in 
immunodepleted ICM in the absence of exogenous activin 
A. This may indicate that secreted activin A is associated 
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with follistatin and is removed upon immunodepletion of 
ICM with follistatin-specific antibodies. This possibility is 
consistent with our model of iris-derived follistatin as an 
inhibitor of somatostatin induction in ciliary neurons. 
Activin A and follistatin may not be the only regulators 
of somatostatin expression. Activin A signals through a 
receptor serine/threonine kinase complex expressed in 
several isoforms (reveiwed in Vale et al., 1991 ; Mathews, 
1994). Regulation may occur through expression of differ- 
ent levels or isoforms of either the type I or type II receptors 
on the choroid and ciliary neurons. Posttranslational pro- 
cessing has also been shown to regulate activity of several 
members of the transforming growth factor 13 superfamily 
(reviewed in Kingsley, 1994), and such processing may 
occur for activin A in this system by regulating its availabil- 
ity in an active form at the synapse, The inhibins, which 
share a common subunit with the activins, have been 
shown to block activin A function in some systems (Yu et 
al., 1987; Ying, 1989). However, inhibin A was unable 
to affect somatostatin expression in our in vitro assay, 
suggesting that it does not function in the establishment 
of neurotransmitter phenotype in the ciliary ganglion (Cou- 
Iombe et al., 1993). Our activin A reagents are specific for 
inhibin 13A but do not distinguish among family members 
that contain the common ~A subunit. Thus, our results 
do not rule out a role for other 13A-containing proteins. 
Interestingly, the partial inhibition seen with follistatin- 
immunodepleted ICM (Figure 7A) suggests that other fac- 
tors, in addition to follistatin, may act to inhibit soma- 
tostatin expression. Finally, other molecules may be re- 
quired to make cells competent to respond to activin 
signaling. Such a requirement has been demonstrated in 
the fibroblast growth factor-dependent, activin-mediated 
induction of mesoderm in early Xenopus development 
(Cornell and Kimelman, 1994; LaBonne and Whitman, 
1994). 
Although these possibilities are intriguing, we do not 
think they detract from the model we propose based on 
the results of this study: that limited expression of somato- 
statin in the neurons of the ciliary ganglion results from a 
differential expression of activin A and its inhibitory binding 
protein, follistatin, in the distinct targets of these neurons. 
Our results show a unique role for the antagonistic func- 
tions of endogenous activin A and follistatin in the regula- 
tion of neurotransmitter phenotype during development. 
This study bridges the gap between an in vitro demonstra- 
tion of neurotransmitter phenotype regulation and the ap- 
propriate temporal and spatial in vivo expression of the 
molecules. 
Experimental Procedures 
Tissue Collection and Cell Culture 
Iris Cell Cultures 
Ell chick irises were isolated in Earle's balanced salt solution 
(GIBCO-BRL, Grand Island, NY) by removing the eve dying cornea and 
cutting inside the iris/ciliary body boundary, iris stroma was separated 
from the pigmented epithelium and mechanically dissociated in modi- 
fied Puck's glucose solution by trituration through a reduced bore 
Pasteur pipette. Following dissociation, cells were filtered through 130 
mm 2 polyamide nylon mesh (Tetko, Inc., Briarcliff Manor, NY) and 
plated at 5 x 104 cells/ml. Iris cultures were grown for 48 hr on polymer- 
ized, collagen-coated 24-well tissue culture plates (Linbro; Flow Labo- 
ratories, Inc., McLean, VA) in 500 p~l of L15 plus 10% horse serum. 
Myotubes from the iris stromal cultures were allowed to differentiate 
by replacing serum-containing medium with serum-free medium. Se- 
rum-free L15 was supplemented with 2.5 mg/ml bovine serum albumin, 
25 mg/ml ovotransferrin, 30 nM selenium, and 2.5 mg/ml insulin 
(Sigma Chemical Co., St. Louis; MO). Both serum-containing and se- 
rum-free L15 included 6 mg/ml glucose, 20 U/ml penicillin, 2 mM gluta- 
mine, and 2 mg/ml streptomycin (GIBCO-BRL). 
Choroid Cultures 
Choroid cells were prepared as previously described (Coulombe and 
Nishi, 1991). Cells were plated on tissue culture dishes coated with 
rat tail collagen and grown in modified L15 medium supplemented with 
10% chick serum and penicillin/streptomycin/glucose, as described 
above, for 2 days. Cells were transferred to serum-free conditions 
supplemented as described for iris cultures. 
Constructs 
A fragment of chick ribosomal protein" $17 (CHRPS) of 361 bp was 
obtained by RT-PCR (Beverly, 1991) using the primer pair based on 
the published sequence (Tr=3eb et-al., 1988): forward, 49-67, and re- 
verse, 389-409, with cycling conditions of 93°C (melting), 54°C (an- 
nealing), and 72°C (extension), for 1 min each (30 cycles) with 1 U 
of Taq DNA polymerase per reaction (Promega, Madison, Wl). The 
fragment was subcloned into pBluescript SK+/- (Stratagene, La Jolla, 
CA). A fragment of chick follistatin was obtained by RT-PCR from 
E17 ovary using Xenopus primers from a region conserved between 
Xenopus and human follistatin sequences (Hemmati-Brivantou and 
Melton, 1994b). The primers recognized an equivalent region in the 
rat fotlistatin gene that crossed the exon 4/5 boundary (Shimasaki et 
al., 1989). In chick, there does not appear to be an exon boundary in 
the region covered by the primers, as no shift in size of the 223 bp 
product was observed when the primers were used to amplify genomic 
DNA. The 223 bp fragment was generated with the primer pair from 
the published sequence: forWard, 639-658, and reverse, 842-862, 
with the same amplification conditions used for CHRPS. The chick 
follistatin was cloned into the pCRil vector (Invitrogen, San Diego, CA). 
The sequence of the inserts was confirmed by Sequenase sequenc- 
ing analysis. A full-length chick inhibin 13A cDNA in pBluescript 
was a generous gift from Dr. Patricia Johnson, Cornell University, 
Ithaca, NY. 
Template and Probe Production 
Templates for ribeprobe production were generated by linearizing con- 
structs in the multiple cloning site or within the insert o generate blunt 
ends or 5' overhangs. Linearize~ templates were treated with 50 I~g/ 
ml proteinase K, 1% SDS for 30 min"at 37°C. The solution was ex- 
tracted with an equal volume of phenol:chloroform:isoamyl alcohol in 
a ratio of 25:24:1. The aqueous pha~e was precipitated with 0.1 vol 
of 3M sodium acetate (pH 7.0) and 2.5 vot of 1000/o ethanol and kept 
at -20°C for at least 1 hr. Pellets were spun and washed one time 
with 70% ethanol. The DNA was resuspended in H20 for storage at 
-20°C. Riboprobes were generated in the following reaction mix: 12.5 
~M cold rCTP (250 I~M cold rCTP for CHRPS), 1 x transcription buffer, 
10 mM dithi0threitol, 10 U of RNasin, 500 I~M rUTP, 500 ~M rATP, 
500 I~M rGTP, 750 ng of template, 25 ~Ci of [32P]rCTP (3000 Ci/mmol), 
and t0 U of bacterial RNA pol~/merase. The free nucleotides and the 
RNasin were purchased from Promega, and the remaining reagents 
were from GIBCO-BRL. The mix was incubated for 1 hr at 37°C, 
and the remaining template was removed by digestion with 10 U of 
RNase-free DNase I. Proteinase K treatment and extraction were as 
described for template production. The probes were precipitated with 
1 p.I of 10 mg/ml glycogen plus sodium acetate and ethanol, as before. 
Probes were routinely generated with activity greater than 107 dpm 
prior to purification. Full-length probes were purified essentially as 
described (Gilman, 1991), with the following modification: the gel band 
was crushed with a tube pestle and extracted in 500 ~1 of 0.3 M NaCI, 
0.5% SDS, 10 mM Tris (pH 7.5) for 45 min on a rocker at 37°C. Purified 
probes were suspended in 40 ~1 of hybridization buffer (40 mM PIPES 
[pH 6.7], 0.4 M NaCI, 1 mM EDTA) and combined in the hybridization 
mix at 10 ~ dpm each for activin A an d follistatin and 104 dpm for C H R PS. 
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RNase Protection Assay 
Total RNA was obtained from embryonic tissue or cells in culture using 
acid phenol extraction (Chomczynski and Sacchi, 1987). Purified pel- 
lets were resuspended in hybridization buffer. Total RNA and probes 
were mixed and hybridized 15-18 hr at 42°C. Protection and pro- 
cessing were done as described (Gilman, 1991). Protected fragments 
for activin A, follistatin, and CHRPS were 410, 223, and 122 bp, respec- 
tively. The unprotected probes ran 20-70 bases higher than the pro- 
tected fragments. Fragments were run on 6% acrylamide/8 M urea/ 
0.5 x TBE gels. Dried gels were exposed to autoradiographic film 
(X-omat; Imaging Products International, Simi Valley, CA) and phos- 
phorimager screens (Molecular Dynamics, Sunnyvale, CA). 
Analysis of mRNA Levels 
The phosphorscreen image was scanned using Scanner Control SI 
(Molecular Dynamics) at 200t~ resolution. Relative signal intensity from 
the scanned phosphorimage was determined using the IPLab Gel soft- 
ware (Signal Analytics, Vienna, VA) to generate the values for pro- 
tected fragments. Relative intensity for activin A and follistatin mRNA 
was expressed as a ratio to the relative intensity of CHRPS mRNA to 
obtain the RNA value. Normalization to the CHRPS loading control 
allowed for comparison between samples and eliminated variation in 
sample handling. 
Preparation of ICM 
Iris cultures were differentiated in serum-free L15 for 3 days to allow 
large multinucleated myotubes to form. Cultures were then fed with 
fresh serum-free L15, and ICM was collected 48 hr later. ICM was 
centrifuged at t000 x g at 4°C and concentrated 6-fold in a 10 kDa- 
cutoff Centriprep filter unit (Amicon, Beverly, MA). Concentrated ICM 
was sterile filtered through a 0.22 p,m filter and stored at -80°C prior 
to use in the somatostatin induction assay. 
Bioassay for Somatostatin Induction 
Neuronal Culture 
Somatostatin expression was assayed by immunoreactivity in cultured 
E8 ciliary ganglion neurons as previously described (Coulombe and 
Nishi, 1991). In brief, ciliary ganglia were dissociated and plated at a 
density of one ganglion per well into drilled 35 mm 2 tissue culture 
dishes. Cut (1.5 cm 2) Petriperm biomembrane (Heraeus Instruments, 
Inc., South Plainfield, N J) had been glued under the 1 cm hole, and 
the resulting well was coated with poly-D-lysine (100 rag) and then 
laminin (2 mg) prior to plating. Neurons were grown in the presence 
of 1 ng/ml recombinant growth-promoting activity (Finn and Nishi, sub- 
mitted) to promote survival (Eckenstein et al., 1990). Growth-promoting 
activity has no somatostatin induction capacity in this assay (Coulombe 
et al., 1993). Dose responses (0-50 ng/ml) of recombinant human 
activin A (Genentech, San Francisco, CA) were tested in the presence 
of 2 x concentrated serum-free L15 or 2 x concentrated ICM for 5 
days in a volume of 200 I~1. Medium was changed every 36 hr. 
Immunocytochemistry 
After the 5 day culture in the described medium, neurons were pro- 
cessed for double peroxidase-antiperoxidase immunoreactivity 
(Vacca et al., 1980) using a rabbit anti-somatostatin antiserum (INC 
Star Corp., Stillwater, MN) as described (Coulombe and Nishi, 1991) 
with some modifications. Cultures were incubated with goat anti-rabbit 
antiserum (Sternberger Immunochemicals, Baltimore, MD) at a dilu- 
tion of 1:125 in blocking solution, and Activity Select peroxidase-rabbit 
antiperoxidase complex (Sternberger Immunochemicals) was used at 
1:200 in blocking solution. Blocking solution consisted of 10% horse 
serum, 5% chick serum, 2% lamb serum, !% Triton X-100 in PBS. 
Normal rabbit serum staining was performed as a control for nonspe- 
cific immunoreactivity. 
Immunodepletion 
Immunodepletion was accomplished by repeatedly passing 10 ml of 
ICM through a 1 ml Hi-trap protein G column (Biorad, Hercules, CA) 
to which 50 ~1 of anti-follistatin antiserum (Sugawara et al., 1990) had 
been bound. Antibody binding to the column was monitored by the 
absence of immunoreactivity on cultured iris myotubes with the 
flowthrough. 
Immunoreactivity Scoring 
The number of neurons containing somatostatin immunoreactivity 
(SOM IR) was viewed under a Zeiss microscope with a 40 x objective 
using bright-field optics. A neuron was defined as an ovoid cell with 
an axonal process at least two cell diameters long. SOM IR was scored 
positive if the cytoplasm contained punctate dark brown diaminobenzi- 
dine reaction product. Ten fields of view were scored for SOM IR- 
positive neurons and total neurons for each well. Three wells for each 
condition tested were included in each experiment. Percentage of 
SOM IR was determined by summing the SOM IR-positive neurons 
per well and dividing by the total neurons per well. Mean percentage 
of SOM IR and SD were determined using percentage of SOM IR from 
each well from one representative experiment. A one-way ANOVA 
followed by Scheffe's multiple range test was used to assess the statis- 
tical significance of the results. 
Determination of Neuronal Survival and ChAT Activity 
Neuronal survival per culture was determined by adding the number 
of neurons in ten fields of view at 400x. Reported values were the 
average of three cultures from one representative xperiment. A one- 
way ANOVA followed by Scheffe's multiple-range test was used to 
assess the statistical significance of the results. ChAT activity was 
determined as described (Coulombe and Nishi, 1991). 
Activin A and Follistatin Immunolocalization 
Antibodies 
Rabbit anti-follistatin antiserum (Sugawara et al., 1990) was a gener- 
ous gift from Dr. Shunichi Shimasaki, The Whittier Institute, La Jolla, 
CA. Rabbit anti-inhibin 6A antiserum and activin A peptide 81-'3 
(Vaughan et al,, 1989) were generous gifts from Dr. Wylie Vale, The 
Salk Institute, La Jolla, CA. 
Cultured Cell Immunohistochemistry 
Iris or choroid cell cultures were established on collagen-coated glass 
coverslips and maintained for 6 days. On day 6, cultures were fixed 
in fresh Zamboni's fixative for 20 min and washed in PBS. Cultures 
were then incubated at 4°C overnight in blocking solution. Polyclonal 
rabbit anti-inhibin #A or anti-follistatin antiserum diluted 1:500 in 
blocking solution was then incubated for 2 hr at 25°C. Antibody local- 
ization was detected using single peroxidase-antiperoxidase staining. 
Specificity was controlled for by comparing staining in the absence 
of a primary antibody or incubating with normal rabbit serum instead 
of primary antibody. Anti-inhibin 13A specificity was further tested by 
preabsorbing 15 #1 of the antiserum with 100 p.g of the activin pep- 
tide 8~-~3 used to generate the antiserum. 
Cryostat Section Immunohistochemistry 
Whole eyes from E11 and E12 chick embryos were removed and fixed 
in fresh Zamboni's fixative for 30 min at 25°C. Histologically reliable 
cryostat sections of choroid younger than E12 could not be obtained. 
The eyes were then washed three times with 30 rain incubations in 
PBS prior to equilibration in OCT embedding medium (TissueTek, 
Elkhart, IN). Sections (12 p.m) were cut on a Leica Jung Frigocut 2800N 
cryostat. Sections were mounted on gelatin-coated glass slides and 
processed for double peroxidase anti-peroxidase staining. Specificity 
controls were performed as for culture staining. 
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